Phase 2 The Combined Approach to Lysis Utilizing Eptifibatide and Rt-PA in Acute Ischemic Stroke-Full Dose Regimen.
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Eptifibatide (Primary)
- Indications Stroke
- Focus Adverse reactions
- Acronyms CLEAR-FDR
- 19 Feb 2016 Results of pooled analysis (n=247) of this and other 2 trials (CLEAR and CLEAR-ER) presented at the 41st International Stroke Conference
- 27 May 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 08 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov